What we do
It is our mission to unravel the molecular details of the working of cells in their normal function and the perturbed functioning in diseased cells. We help translate our knowledge and technologies to clinical practice.
Research
Our common goal is simple and easily described, but the road we take and focus points we have in our science are very diverse. Ranging from virus biology to genome editing, diabetes and oncogenic signaling, our scope of interest covers a wide area of life science.
Affiliated labs
We collaborate with some of the worlds leading institutes in all field of science. Some of the labs we affiliate with and their leaders that hold positions at our department are:
Prof. Hidde Ploegh appointed as Jon J. van Rood-scholar ( Harvard Medical School, United States of America)
Prof. Brenda Schulman appointed as LUF-Boerhaave Visiting Professor (Max-Planck Institute, Martinsried, Germany)
News
-
-
Virtual ChemBio symposium
-
The diabetes group has described the extreme diversity of the beta cell translatome
-
ZonMw funding of 750,000 euros for Monitoring cellular stress in insulin-producing cells by live imaging
-
ZonMw funding of 750,000 euros for Targeting the Mesenchymal Cancer Cell Phenotype for Therapeutic Gain
-
Standardization of Electron Microscopy Data for Artificial Intelligence
Cases
-
Academic Pharma
Academic Pharma is one of the ten research themes of the LUMC, that aim to form a cross-departmental environment in which connection and quality of research are optimally stimulated. Within Academic Pharma innovative new drugs (or new drug targets) will be discovered and developed. Outstanding academic biomedical research has proven to form the basis for new drug targets and innovative treatments.
read more -
PEP-TALKS for LUMC Patients and Personnel
What is really going on at the LUMC labs and research departments?
read more -
Clinical Internships
CCB department initiated Clinical Internships to bridge the fundamental research with the clinical practice.
read more